Follow The Filings

KKR

KKR earnings company data as of 4:47 AM ET 10/24

  • 12 Owners
  • Rank #73
  • Max 8.9%
  • Master 0.13%

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS 1.42 — —
Rev — — —

Who owns this now

Largest portfolio weights among holders, up to 8.9% (Chuck Akre, Akre Capital Management). Not free-float ownership.

All holders
  1. Chuck Akre Reduce 8.9%
  2. Scott Miller Add 6.8%
  3. Valueact Capital Add 5.8%
  4. Estuary Capital Management Add 4.3%
  5. Lindsell Train New 2.3%
  6. Farallon Capital Management Reduce 1.7%

Insider trades

Open-market buys and sales by KKR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KKR insider trades
  • $50.9M bought by 5 insiders
  • $1.1M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Dane E Holmes Chief Administrative Officer
    Sale
    $1.1M 10,000 shares at $108.58 54% of stake
    Traded Sep 3 Filed Sep 4
  2. Timothy R Barakett Director
    Buy
    $4.7M 50,000 shares at $94.47 +21% to stake
    Traded Mar 4 Filed Mar 5
  3. Scott C Nuttall CEO
    Buy
    $4.4M 50,000 shares at $87.81 +0.3% to stake
    Traded Feb 27 Filed Mar 3
  4. Joseph Y Bae CEO
    Buy
    $4.4M 50,000 shares at $88.56 +9.8% to stake
    Traded Feb 27 Filed Mar 3
  5. Mary N Dillon Director
    Buy
    $2M 22,225 shares at $90.96 +81% to stake
    Traded Mar 2 Filed Mar 3
  6. Matt Cohler Director
    Buy
    $4.5M 43,872 shares at $102.90 +2734% to stake
    Traded Feb 17 Filed Feb 18
  7. Joseph Y Bae CEO
    Buy
    $12.8M 125,000 shares at $102.19 +33% to stake
    Traded Feb 17 Filed Feb 18
  8. Scott C Nuttall CEO
    Buy
    $12.8M 125,000 shares at $102.66 +0.8% to stake
    Traded Feb 17 Filed Feb 18
  9. Timothy R Barakett Director
    Buy
    $5.2M 50,000 shares at $104.93 +27% to stake
    Traded Feb 9 Filed Feb 11

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants, 4 gifts, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 7.01
8-K 7.01,8.01
10-Q
8-K 1.01,2.03
8-K 2.02,9.01
8-K 5.02,5.07
8-K 5.07
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
DEFA14A
8-K 5.07
DEFA14A
SCHEDULE 13G/A —
DEFA14A
DEFA14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.